Brendan Tarrier Email

VP Research and Development . LynxDx

Current Roles

Employees:
116
Revenue:
$18M
About
LynxDx is working to commercialize a prostate cancer urine diagnostic assay that is able to confidently prevent many unnecessary prostate biopsies. The test, called the MyProstateScore (MPS), is performed in a regulatory-compliant commercial laboratory. To assist in the global response to the COVID-19 pandemic, LynxDx has worked aggressively to repurpose our clinical laboratory infrastructure to offer diagnostic COVID-19 testing.
LynxDx Address
333 Jackson Plaza
Ann Arbor, MI
United States
LynxDx Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.